Suppressor-Cell Antibody in Systemic Lupus Erythematosus
- 1 March 1979
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 63 (3) , 536-539
- https://doi.org/10.1172/JCI109333
Abstract
Circulating antibodies that could be responsible for the suppressor thymus-derived (T)-cell dysfunction in active systemic lupus erythematosus (SLE) were investigated. Sera from 14 active and inactive SLE patients were compared with a pool of 22 normal sera. All sera were adsorbed with a pool of normal platelets to exclude antihistocompatibility leukocyte antigen antibodies; with AB erythrocytes to exclude isohemagglutinins; and with a pool of normal bone marrow-derived (B) lymphocytes, monocytes, and neutrophils to deplete anti-B-cell antibodies, Fc-receptor antibodies, and antibodies directed against neutrophils or monocytes. Sera from active SLE patients were capable of inhibiting the activation of normal, blood lymphocytes by concanavalin A to become suppressor cells. The latter were assayed by coculturing the concanavalin A-activated cells with autologous lymphocytes, which were then activated with either phytohemagglutinin for proliferative response or with pokeweed mitogen for B-cell immunoglobulin (Ig) synthesis and secretion. Specific incorporation of cultures with phytohemagglutinin showed a value of 67±13 (mean±SD) for suppressor cells treated with adsorbed, active SLE sera. This value was significantly different (P < 0.001) from that of cells treated with the inactive SLE sera or with the pool of normal sera. Similar findings were seen with respect to the B-cell target parameters. Cytoplasmic Ig and IgG in supernates of cultures with pokeweed mitogen showed values of 17±5% and 717±134 ng/culture, respectively, for suppressor cells treated with the adsorbed, active SLE sera. This was significantly different from those treated with the inactive SLE sera or with the pool of normal sera. The antisuppressor-cell factor was shown to be IgG, complement independent, not cytotoxic, active at 37°C and at room temperature, but not at 4°C, and adsorbable with T cells. Suppressor T-cell antibody in sera of active SLE patients could be responsible for the observed suppressor T-cell dysfunction seen in active SLE. The mechanisms responsible for the induction of the antisuppressor-cell antibody are unknown.This publication has 19 references indexed in Scilit:
- A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1978
- Studies of immune functions of patients with systemic lupus erythematosus. i. dysfunction of suppressor t‐cell activity related to impaired generation of, rather than response to, suppressor cellsArthritis & Rheumatism, 1978
- Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic EpitheliumScience, 1977
- Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1977
- Suppressor T-cell abnormality in idiopathic systemic lupus erythematosusClinical Immunology and Immunopathology, 1976
- Disordered Immunologic Regulation and AutoimmunityImmunological Reviews, 1976
- FUNCTIONAL CHARACTERIZATION OF A NATURALLY OCCURRING ANTIBODY CYTOTOXIC FOR A SUBPOPULATION OF SPLENIC T CELLSTransplantation, 1976
- Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1976
- Relative T‐Cell Specificity of Lymphocytotoxins from Patients with Systemic Lupus ErythematosusArthritis & Rheumatism, 1973
- The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel FiltrationScandinavian Journal of Clinical and Laboratory Investigation, 1968